

Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info Current Number of Vacancies = 6 Note, one or more vacancies may be in the nomination process or a final appointment may have been made. The names listed below are advisory committee members who have active appointments required to participate in committee meetings, including an unexpired appointment as a Special Government Employee where applicable. Chairperson Vacant Designated Federal Officer (DFO) Takyiah Stevenson, PharmD Division of Advisory Committee and Consultant Management Office of Executive Programs Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, Maryland 20993-0002 Phone: (301) 796-9001 Fax: (301) 847-8533 E-mail: PCAC@fda.hhs.gov Timothy D. Fensky, RPh, DPh FACA Expertise: National Association of Boards of Pharmacy Representative Term: 10/1/2018 – 9/30/2026 President/Principal Consultant Pharmacy Insights 58 Alan Road Marlborough, Massachusetts 01752 Elizabeth Rebello, RPh, MD, FASA, CPPS, CMQ Expertise: Anesthesiology Term: 10/1/2018– 9/30/2026 Professor Department of Anesthesiology and Perioperative Medicine University of Texas MD Anderson Cancer Center 1400 Holcombe Boulevard Houston, Texas 77030 Brian Serumaga, PhD Expertise: United States Pharmacopeia Representative Term: 4/23/2022 – 9/30/2026 Director, Personalized Medicines United States Pharmacopeial Convention 12601 Twinbrook Parkway Rockville, Maryland 20852 **Donnette D. Staas, PhD Expertise: Industry Representative Term: 2/8/2024 to 10/31/2027 Vice President, Regulatory Strategy Jazz Pharmaceuticals 2005 Market Street, Suite 2100 Philadelphia, Pennsylvania 19103 * Consumer Representative (vacant) ** Industry Representative (non-voting) Updated: December 1, 2025
What's New: Drugs
|15th Jan, 2026
|FDA
What's New: Drugs
|15th Jan, 2026
|FDA
What's New: Drugs
|15th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA
What's New: Drugs
|13th Jan, 2026
|FDA